Amir Onn Selected Research

Cisplatin (Platino)

10/2014	Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo.
2/2013	Evaluation of novel orthotopic nude mouse models for human small-cell lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amir Onn Research Topics

Disease

44	Neoplasms (Cancer) 10/2023 - 06/2002
31	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 06/2002
25	Lung Neoplasms (Lung Cancer) 01/2023 - 06/2002
6	Adenocarcinoma of Lung 10/2019 - 06/2002
5	Adenocarcinoma 01/2022 - 01/2017
5	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2002
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 06/2002
3	Carcinoma (Carcinomatosis) 01/2021 - 10/2004
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2019 - 11/2003
3	Melanoma (Melanoma, Malignant) 09/2013 - 02/2004
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 05/2005
2	Pleural Effusion (Pleural Effusions) 01/2022 - 09/2014
2	Malignant Pleural Effusion 01/2022 - 09/2014
2	Asthma (Bronchial Asthma) 05/2021 - 11/2002
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2024
1	Pneumonia (Pneumonitis) 10/2023
1	Respiratory Insufficiency (Respiratory Failure) 06/2023
1	COVID-19 06/2023
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2023
1	Testicular Neoplasms (Testicular Cancer) 01/2022
1	Immune System Diseases (Immune Disorders) 01/2022
1	Respiratory Hypersensitivity 05/2021
1	Pain (Aches) 01/2020
1	Disease Progression 12/2019
1	Weight Loss (Weight Reduction) 01/2019

Drug/Important Bio-Agent (IBA)

9	ErbB Receptors (EGF Receptor)IBA 10/2023 - 01/2004
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 11/2003
6	Tyrosine Kinase InhibitorsIBA 04/2022 - 12/2004
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2013
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2004
5	LigandsIBA 01/2023 - 10/2007
5	Paclitaxel (Taxol)FDA LinkGeneric 10/2014 - 11/2003
3	Phosphotransferases (Kinase)IBA 01/2021 - 02/2007
3	MicroRNAs (MicroRNA)IBA 10/2020 - 09/2013
3	vandetanib (ZD6474)IBA 09/2014 - 02/2007
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 11/2013 - 02/2004
3	Gefitinib (Iressa)FDA Link 07/2012 - 06/2005
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2007 - 01/2005
3	Interleukin-8 (Interleukin 8)IBA 03/2007 - 11/2003
2	Messenger RNA (mRNA)IBA 01/2023 - 08/2021
2	Axitinib (AG 013736)IBA 01/2022 - 04/2021
2	Peptides (Polypeptides)IBA 01/2022 - 02/2016
2	B7-H1 AntigenIBA 01/2022 - 01/2018
2	CytokinesIBA 01/2022 - 01/2021
2	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 02/2007
2	NivolumabIBA 01/2021 - 01/2019
2	PlatinumIBA 12/2019 - 01/2017
2	Etoposide (VP 16)FDA LinkGeneric 12/2019 - 02/2013
2	AntibodiesIBA 11/2018 - 10/2009
2	Pemetrexed (MTA)FDA Link 01/2017 - 10/2014
2	Cisplatin (Platino)FDA LinkGeneric 10/2014 - 02/2013
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2014 - 02/2007
2	Transforming Growth Factor alpha (TGF-alpha)IBA 10/2007 - 01/2004
2	Epidermal Growth Factor (EGF)IBA 10/2007 - 02/2007
2	Angiogenesis InhibitorsIBA 03/2007 - 05/2005
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 03/2007 - 06/2004
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2005 - 01/2003
2	Imatinib Mesylate (Gleevec)FDA Link 01/2005 - 02/2004
2	Platelet-Derived Growth FactorIBA 01/2005 - 02/2004
1	methyl 1- ribofuranosyl- 1,2,4- triazole- 3- carboxamidateIBA 10/2023
1	Monoclonal AntibodiesIBA 10/2023
1	Calcibiotic Root Canal SealerIBA 01/2023
1	AntigensIBA 01/2022
1	Inducible T-Cell Co-Stimulator ProteinIBA 01/2022
1	avelumabIBA 01/2022
1	durvalumabIBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	alectinibIBA 01/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2022
1	pembrolizumabIBA 01/2022
1	palbociclibIBA 01/2022
1	ParaffinIBA 08/2021
1	Bovine Serum AlbuminIBA 08/2021
1	Granzymes (Granzyme)IBA 08/2021
1	Formaldehyde (Formol)FDA Link 08/2021
1	Methacholine Chloride (Methacholine)FDA Link 05/2021
1	Everolimus FDA Link 04/2021
1	CalciumIBA 01/2021
1	InterferonsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Nerve Growth Factors (Neurotrophins)IBA 01/2021
1	Complement System Proteins (Complement)IBA 12/2020
1	Cell-Free Nucleic AcidsIBA 12/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	Conditioned Culture MediaIBA 01/2020
1	cyclopropapyrroloindoleIBA 10/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019

Therapy/Procedure

22	Therapeutics 01/2024 - 06/2002
9	Drug Therapy (Chemotherapy) 01/2021 - 06/2005
8	Radiotherapy 01/2023 - 06/2005
7	Immunotherapy 01/2022 - 01/2019
3	Molecular Targeted Therapy 10/2005 - 05/2005
2	Precision Medicine 01/2021 - 01/2019
2	Catheters 09/2014 - 11/2007
1	Lung Transplantation 01/2024
1	Neoadjuvant Therapy 10/2023
1	Extracorporeal Membrane Oxygenation 06/2023
1	Artificial Respiration (Mechanical Ventilation) 06/2023
1	Ambulatory Care (Outpatient Care) 01/2020